Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parul U Gandhi

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Annals of Global Health|April 23, 2014
Management of chronic heart failure: biomarkers, monitors, and disease management programsParul U Gandhi, Sean Pinney
Current Heart Failure Reports|August 18, 2015
The Current and Potential Clinical Relevance of Heart Failure BiomarkersParul U Gandhi, Jeffrey M Testani, Tariq Ahmad
Analytical Chemistry|March 15, 2005
Electrically assisted sampling across membranes with electrophoresis in nanometer inner diameter capillariesLori A Woods, Parul U Gandhi, Andrew G Ewing
JACC. Heart Failure|May 16, 2016
The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided TherapyAditi Mallick, Parul U Gandhi, Hanna K Gaggin, et al.
Journal of Cardiovascular Translational Research|September 16, 2016
Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart FailureHanna K Gaggin, Arianna M Belcher, Parul U Gandhi, et al.
The American Journal of Cardiology|July 22, 2017
Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection FractionNasrien E Ibrahim, James L Januzzi, Dustin J Rabideau, et al.
Journal of Cardiac Failure|July 30, 2016
Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) StudyNasrien E Ibrahim, Hanna K Gaggin, Dustin J Rabideau, et al.
Journal of Cardiac Failure|December 3, 2014
Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: results from the pro-B-type natriuretic peptide outpatient-tailored chronic heart failure therapy (PROTECT) studyParul U Gandhi, Jackie Szymonifka, Shweta R Motiwala, et al.
Journal of the American College of Cardiology|December 3, 2014
Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist deviceAlan D Enriquez, Brandon Calenda, Parul U Gandhi, et al.
ESC Heart Failure|September 24, 2020
Dying to know: prognosis communication in heart failureCasey E Cavanagh, Lindsey Rosman, Erica S Spatz, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Annals of Global Health|April 23, 2014
Management of chronic heart failure: biomarkers, monitors, and disease management programsParul U Gandhi, Sean Pinney
Current Heart Failure Reports|August 18, 2015
The Current and Potential Clinical Relevance of Heart Failure BiomarkersParul U Gandhi, Jeffrey M Testani, Tariq Ahmad
Analytical Chemistry|March 15, 2005
Electrically assisted sampling across membranes with electrophoresis in nanometer inner diameter capillariesLori A Woods, Parul U Gandhi, Andrew G Ewing
JACC. Heart Failure|May 16, 2016
The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided TherapyAditi Mallick, Parul U Gandhi, Hanna K Gaggin, et al.
Journal of Cardiovascular Translational Research|September 16, 2016
Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart FailureHanna K Gaggin, Arianna M Belcher, Parul U Gandhi, et al.
The American Journal of Cardiology|July 22, 2017
Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection FractionNasrien E Ibrahim, James L Januzzi, Dustin J Rabideau, et al.
Journal of Cardiac Failure|July 30, 2016
Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) StudyNasrien E Ibrahim, Hanna K Gaggin, Dustin J Rabideau, et al.
Journal of Cardiac Failure|December 3, 2014
Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: results from the pro-B-type natriuretic peptide outpatient-tailored chronic heart failure therapy (PROTECT) studyParul U Gandhi, Jackie Szymonifka, Shweta R Motiwala, et al.
Journal of the American College of Cardiology|December 3, 2014
Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist deviceAlan D Enriquez, Brandon Calenda, Parul U Gandhi, et al.
ESC Heart Failure|September 24, 2020
Dying to know: prognosis communication in heart failureCasey E Cavanagh, Lindsey Rosman, Erica S Spatz, et al.
Pageof 4